Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Skin Neoplasm”

1,200 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,200 results

Not applicableStudy completedNCT03372902
What this trial is testing

Development Of A Blood Test To Improve The Performance Of Breast Cancer Screening

Who this might be right for
Breast CancerBreast Benign
Memorial Sloan Kettering Cancer Center 628
Large-scale testing (Phase 3)Study completedNCT00005590
What this trial is testing

Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerExtragonadal Germ Cell Tumor+7 more
Cancer Research Campaign Clinical Trials Centre
Not applicableEnrolling By InvitationNCT06388252
What this trial is testing

Electrochemotherapy Induces Changes in the Tumor Microenvironment of Cutaneous and Subcutaneous Metastases in Patients With Cutaneous Melanoma

Who this might be right for
Cutaneous Malignant Melanoma
Institute of Oncology Ljubljana 10
Early research (Phase 1)Study completedNCT01107418
What this trial is testing

A Pharmacokinetic/Pharmacodynamic Study of RO5185426 in Previously Treated Patients With Metastatic Melanoma

Who this might be right for
Malignant Melanoma
Hoffmann-La Roche 52
Not applicableStudy completedNCT05364450
What this trial is testing

Facilitating Adaptive Coping With Fear of Recurrence Among Breast Cancer Survivors

Who this might be right for
Breast NeoplasmBreast CancerBreast Carcinoma+9 more
Indiana University 390
Testing effectiveness (Phase 2)Study completedNCT00350597
What this trial is testing

GM-CSF as Adjuvant Therapy of Melanoma

Who this might be right for
Malignant Melanoma
Northern California Melanoma Center 50
Not applicableStudy completedNCT02129049
What this trial is testing

Telephone-Based Educational Intervention in Improving Communication Between Patients With Stage 0-III Cancer and Their Children

Who this might be right for
Breast CancerCervical CancerColon Cancer+5 more
University of Washington 35
Early research (Phase 1)Study completedNCT03084640
What this trial is testing

Phase 1B Study Evaluating Alternative Routes of Administration of CMP-001 in Combination With Pembrolizumab in Participants With Advanced Melanoma

Who this might be right for
Malignant Melanoma
Regeneron Pharmaceuticals 30
Early research (Phase 1)Looking for participantsNCT04038619
What this trial is testing

Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients

Who this might be right for
ColitisDiarrheaMalignant Genitourinary System Neoplasm+6 more
M.D. Anderson Cancer Center 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT04083599
What this trial is testing

GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors

Who this might be right for
Malignant Solid TumorNon-Small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)+3 more
Genmab 350
Not applicableLooking for participantsNCT07072143
What this trial is testing

An International Study on Pediatric Patients With Rare Tumors.

Who this might be right for
Paraganglioma/ PhaeochromocytomaMelanoma and Other Malignant Neoplasms of SkinGastrointestinal Stromal Tumor (GIST)+11 more
Azienda Ospedaliera di Padova 6,250
Not applicableStudy completedNCT02662621
What this trial is testing

Pilot Study With the Aim to Quantify a Stress Protein in the Blood and in the Urine for the Monitoring and Early Diagnosis of Malignant Solid Tumors

Who this might be right for
Cancer
Centre Georges Francois Leclerc 71
Testing effectiveness (Phase 2)Ended earlyNCT05551117
What this trial is testing

Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid Tumors

Who this might be right for
Castration-Resistant Prostatic CancerAndrogen-Independent Prostatic CancerAndrogen-Insensitive Prostatic Cancer+14 more
MacroGenics 192
Testing effectiveness (Phase 2)Study completedNCT00445458
What this trial is testing

HKI-272 (Neratinib) in Combination With Paclitaxel (Taxol) in Subjects With Solid Tumors and Breast Cancer

Who this might be right for
Advanced Breast CancerAdvanced Malignant Solid TumorsBreast Neoplasms
Puma Biotechnology, Inc. 110
Not applicableActive Not RecruitingNCT04174391
What this trial is testing

Lifestyles and Breast Cancer

Who this might be right for
Malignant Tumor of Breast
University of Navarra 766
Testing effectiveness (Phase 2)Study completedNCT05159778
What this trial is testing

Phase 2 Study of Imprime PGG and Pembrolizumab in Patients With HR+/HER2- Metastatic Breast Cancer (mBCA)

Who this might be right for
Malignant Neoplasm of Breast
HiberCell, Inc. 26
Testing effectiveness (Phase 2)Study completedNCT00041808
What this trial is testing

Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver

Who this might be right for
Metastases, NeoplasmColorectal NeoplasmsEsophageal Neoplasms+9 more
FeRx 20
Not applicableStudy completedNCT00002520
What this trial is testing

Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+7 more
Eastern Cooperative Oncology Group 434
Early research (Phase 1)Study completedNCT03158935
What this trial is testing

The ACTIVATE (Adoptive Cell Therapy InVigorated to Augment Tumor Eradication) Trial

Who this might be right for
Advanced Ovarian CancerMalignant Melanoma
University Health Network, Toronto 8
Not applicableUnknownNCT03454282
What this trial is testing

Impact of Dietary Intervention on Tumor Immunity: the DigesT Trial

Who this might be right for
Breast CancerMelanoma, Malignant
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 100
Load More Results